Asensus Surgical, Inc. (ASXC)
Aug 22, 2024 - ASXC was delisted (reason: acquired by KARL STORZ)
0.3500
0.00 (0.00%)
Inactive · Last trade price on Aug 21, 2024

Company Description

Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia.

It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients.

The company’s products include Senhance System, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures; instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue.

The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021.

Asensus Surgical, Inc. is headquartered in Durham, North Carolina.

Asensus Surgical, Inc.
Asensus Surgical logo
CountryUnited States
Founded2006
IndustryMedical Devices
SectorHealthcare
Employees209
CEOAnthony Fernando

Contact Details

Address:
1 TW Alexander Drive, Suite 160
Durham, North Carolina 27703
Phone919 765 8400
Websiteasensus.com

Stock Details

Ticker SymbolASXC
ExchangeNYSEAMERICAN
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0000876378
CUSIP Number04367G103
ISIN NumberUS04367G1031
Employer ID11-2962080
SIC Code3841

Key Executives

NamePosition
Anthony FernandoPresident, Chief Executive Officer and Director
Shameze Rampertab B.Sc. MBA, CA, CPAExecutive Vice President and Chief Financial Officer
Joshua B. WeingardChief Legal Officer and Secretary
Ethan LoiselleVice President of Global Marketing
Ravi KommineniHead of Global Quality and Regulatory
Motti FrimerVice President of Research & Development, Digital Solutions and MD of Asensus Surgical

Latest SEC Filings

DateTypeTitle
Aug 22, 2024S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Aug 22, 2024S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Aug 22, 2024S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Aug 22, 2024S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Aug 22, 2024S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Aug 22, 2024S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Aug 22, 2024S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Aug 22, 2024S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Aug 22, 2024S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Aug 22, 2024S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments